A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated with Colchicine Prophylaxis
Objective This study investigated that serum metabolomics, prior to ULT initiation, could serve as a biomarker for responsiveness to colchicine prophylaxis in patients with gout commencing treat‐to‐target ULT. Methods We studied a multicenter prospective cohort (n=409) initiatin…